Key statistics
As of last trade AGC Inc (SHJ:MUN) traded at 37.40, 0.00% below its 52-week high of 37.40, set on Feb 27, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 37.40 |
|---|---|
| High | 37.40 |
| Low | 37.40 |
| Bid | 37.20 |
| Offer | 37.80 |
| Previous close | 37.40 |
| Average volume | 14.29 |
|---|---|
| Shares outstanding | 217.43m |
| Free float | 197.71m |
| P/E (TTM) | 21.25 |
| Market cap | 1.51tn JPY |
| EPS (TTM) | 326.18 JPY |
| Annual div (ADY) | 1.14 EUR |
|---|---|
| Annual div yield (ADY) | 3.06% |
| Div ex-date | Dec 29 2025 |
| Div pay-date | Mar 30 2026 |
| Next div ex-date | Jun 29 2026 |
| Next div pay-date | Sep 01 2026 |
Data delayed at least 15 minutes, as of Mar 02 2026 07:07 GMT.
More ▼
- AGC Biologics Seattle Site Now Certified to Manufacture Biologics for Largest Pharmaceutical Market in South America
- AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome
- Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
- AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development
